» Authors » Tzung-Jiun Tsai

Tzung-Jiun Tsai

Explore the profile of Tzung-Jiun Tsai including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 254
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang C, Wei S, Shieh M, Chou J, Chuang C, Wang H, et al.
J Formos Med Assoc . 2025 Feb; PMID: 39893095
Background: Despite industrialization and advances in healthcare, the prevalence of inflammatory bowel disease (IBD), which encompasses Crohn's disease (CD) and ulcerative colitis (UC), is increasing in Taiwan. Population-based studies can...
2.
Wu H, Weng M, Chou J, Yen H, Lin C, Chiang F, et al.
Clin Transl Gastroenterol . 2024 Dec; 16(2):e00798. PMID: 39636008
Introduction: We explored the clinical characteristics, treatment, and outcomes of colitis-associated colorectal cancer (CAC) and compared with sporadic colorectal cancer in Taiwan. Methods: In this retrospective study spanning 1987-2022, CACs...
3.
Wu J, Yen H, Wang H, Chang T, Chang C, Chang C, et al.
Intest Res . 2024 Aug; 22(3):250-285. PMID: 39099218
Crohn's disease (CD) is a chronic, fluctuating inflammatory condition that primarily affects the gastrointestinal tract. Although the incidence of CD in Taiwan is lower than that in Western countries, the...
4.
Yen H, Wu J, Wang H, Chang T, Chang C, Chang C, et al.
Intest Res . 2024 Aug; 22(3):213-249. PMID: 39099217
Ulcerative colitis (UC) is a chronic inflammation of the gastrointestinal tract and is characterized by alternating periods of inflammation and remission. Although UC incidence is lower in Taiwan than in...
5.
Lin K, Liao J, Chen Y, Wang H, Sun W, Kao S, et al.
J Formos Med Assoc . 2023 Aug; 123(2):238-247. PMID: 37586970
Background: The percentage of and factors associated with the regression of Barrett's esophagus (BE) or its characteristic intestinal metaplasia (IM) remain unclear, and conflicting results have been reported because of...
6.
Lin W, Tai W, Chang C, Tu C, Feng I, Shieh M, et al.
Inflamm Bowel Dis . 2023 Jan; 29(11):1730-1740. PMID: 36626567
Background: This nationwide prospective registry study investigated the real-world effectiveness, safety, and persistence of vedolizumab (VDZ) in inflammatory bowel disease (IBD) patients in Taiwan. Disease relapse rates after VDZ discontinuation...
7.
Chou J, Chung C, Huang T, Tu C, Chang C, Chang C, et al.
Gastroenterol Res Pract . 2021 Nov; 2021:9574737. PMID: 34840565
Background And Aims: Patients with Meckel's diverticulum (MD) are difficult to preoperatively diagnose because of its endoscopic inaccessibility. Balloon-assisted enteroscopy (BAE) allows endoscopic access to the entire small intestine. The...
8.
Chang C, Chen W, Tsay F, Wang H, Tsai T, Hsu C
Colorectal Dis . 2021 Nov; 24(3):343. PMID: 34821444
No abstract available.
9.
Lu C, Cheng J, Sun W, Chen W, Tsay F, Wang H, et al.
Antimicrob Agents Chemother . 2021 Nov; 66(2):e0166421. PMID: 34807763
Spontaneous severe acute exacerbation (SAE) is not uncommon in the natural history of chronic hepatitis B (CHB). Lamivudine (LAM) has the advantages of low price, quick onset, good efficacy, and...
10.
Sun W, Tang P, Chen W, Tsay F, Wang H, Tsai T, et al.
Front Med (Lausanne) . 2021 Aug; 8:657109. PMID: 34336877
Reactivation of the hepatitis B virus (HBV) during cancer chemotherapy is a severe and sometimes fatal complication. In 2009, the National Health Insurance (NHI) in Taiwan recommended and reimbursed screening...